Mayo Clinic Proceedings Essential to Clinical Practice, According to New Survey

Rochester, MN, April 9, 2012 – The recently released 2011 Enhanced Essential Journal Study assessing journal importance and readership among physicians in the United States identifies Mayo Clinic Proceedings as one of the top “must-read” journals in internal medicine. Proceedings ranked fourth, behind only The New England Journal of Medicine, Journal of the American Medical Association, and Annals of Internal Medicine, as a journal internists consider “essential” to their practice and “important in clinical decision-making”. The Proceedings was also ranked among the top 10 essential journals for cardiologists (#9), hospitalists (#7), and pulmonologists (#10).

“The Editorial Board is extremely pleased with this recognition of Mayo Clinic Proceedings,” said William L. Lanier, MD, Editor-in-Chief. “Given that these data were collected immediately before the January 2012 launch of the redesigned print journal and website, and before the contributions of our new publisher Elsevier would have had an impact, we are optimistic that the journal’s importance to physicians’ knowledge, clinical practice, and professionalism will continue to grow.”

This annual independent syndicated study was conducted by the Matalia Group, Inc.* on behalf of The New England Journal of Medicine via mail to AMA physicians in 10 specialties. It identified which journals physicians consider “essential”, defined as reporting medical breakthroughs and having practice-changing impact, as well as secondary journals that physicians find relevant and are read less frequently.

According to the study 29% of internists agree that the Proceedings improves their understanding of medicine and read the journal regularly or when they can. The Proceedings was also the third ranked journal in internal medicine for online readership. 

“These results reflect the significant impact that Mayo Clinic Proceedings has, not just in internal medicine, but across a wide range of specialties,” said Pamela Poppalardo, Publishing Director at Elsevier. “We are excited to be working with Mayo Clinic to accelerate the journal’s growth and impact.”

 

# # #


Notes for editors
*2011 Enhanced Essential Journal Study, commissioned by The New England Journal of Medicine, was conducted by The Matalia Group, Inc. Interested parties may contact Sima Sherman at ssherman@triplethreatmedia.com to review these findings.

Contact Eileen Leahy at +1 732 238 3628or e.leahy@elsevier.com for additional information. Journalists wishing to set up interviews with William L. Lanier, MD, Editor-in-Chief, should contact Peg Wentz, Editorial Assistant, at wentz.margaret@mayo.edu or the journal office at +1 507 284 2094 or proceedings@mayo.edu.

About Mayo Clinic Proceedings
The flagship journal of Mayo and one of the premier peer-reviewed clinical journals in general medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 124,000. While the Proceedings is sponsored by Mayo Clinic, it welcomes submissions from authors worldwide, publishing articles that focus on clinical medicine and support the professional and educational needs of its readers. www.mayoclinicproceedings.org. The journal’s mission is to promote the best interests of patients by advancing the knowledge and professionalism of the physician community.

About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research, and education for people from all walks of life. For more information visit www.mayoclinic.org/about / and www.mayoclinic.org/news.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Eileen Leahy
Elsevier
+1 732 238 3628
e.leahy@elsevier.com